ES2161698T3 - Anticuerpos especificos contra plaquetas activadas, su produccion y su utilizacion en la diagnosis y terapia. - Google Patents
Anticuerpos especificos contra plaquetas activadas, su produccion y su utilizacion en la diagnosis y terapia.Info
- Publication number
- ES2161698T3 ES2161698T3 ES93100339T ES93100339T ES2161698T3 ES 2161698 T3 ES2161698 T3 ES 2161698T3 ES 93100339 T ES93100339 T ES 93100339T ES 93100339 T ES93100339 T ES 93100339T ES 2161698 T3 ES2161698 T3 ES 2161698T3
- Authority
- ES
- Spain
- Prior art keywords
- diagnosis
- therapy
- production
- antibodies against
- specific antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA INVENCION SE REFIERE A ANTICUERPOS MONOCRONALES Y SUS PARTES, QUE LIGAN DE FORMA PREFERENCIAL EN PLAQUETAS HUMANAS ACTIVAS, LA SECUENCIA DE NUCLEOTIDOS Y AMINOACIDOS DE CADENAS LIGERAS O PESADAS EL MAK BW 2128 Y UN ANTIGENO ASOCIADO CON LA TROMBOSPONDINA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4203545A DE4203545A1 (de) | 1992-02-07 | 1992-02-07 | Spezifische antikoerper gegen aktivierte plaettchen, ihre herstellung und ihre verwendung in diagnose und therapie |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2161698T3 true ES2161698T3 (es) | 2001-12-16 |
Family
ID=6451181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93100339T Expired - Lifetime ES2161698T3 (es) | 1992-02-07 | 1993-01-12 | Anticuerpos especificos contra plaquetas activadas, su produccion y su utilizacion en la diagnosis y terapia. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5686583A (es) |
EP (1) | EP0554670B1 (es) |
JP (1) | JP3821858B2 (es) |
AT (1) | ATE205255T1 (es) |
AU (1) | AU669870B2 (es) |
CA (1) | CA2088889C (es) |
DE (2) | DE4203545A1 (es) |
ES (1) | ES2161698T3 (es) |
NO (1) | NO930406L (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8034904B2 (en) * | 2002-06-14 | 2011-10-11 | Immunogen Inc. | Anti-IGF-I receptor antibody |
US7538195B2 (en) * | 2002-06-14 | 2009-05-26 | Immunogen Inc. | Anti-IGF-I receptor antibody |
US7655411B2 (en) * | 2002-08-23 | 2010-02-02 | W2 Holdings, Inc. | Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4610960A (en) * | 1983-12-21 | 1986-09-09 | Wisconsin Alumni Research Foundation | Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin |
EP0387380A1 (en) * | 1989-03-17 | 1990-09-19 | BEHRINGWERKE Aktiengesellschaft | Mutants of urinary plasminogen activator, their production and use |
AU6964891A (en) * | 1989-11-03 | 1991-05-31 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Novel monoclonal antibody against human platelets |
US5192744A (en) * | 1990-01-12 | 1993-03-09 | Northwestern University | Method of inhibiting angiogenesis of tumors |
US5200397A (en) * | 1990-02-22 | 1993-04-06 | W. R. Grace & Co.-Conn. | Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity |
WO1992017499A1 (en) * | 1991-04-08 | 1992-10-15 | Cornell Research Foundation, Inc. | A unique hexapeptide derived from thrombospondin and its uses |
CA2063055A1 (en) * | 1991-05-22 | 1992-11-23 | Jacob Eyal | Peptides having thrombospondin-like activity and their therapeutic use |
-
1992
- 1992-02-07 DE DE4203545A patent/DE4203545A1/de not_active Withdrawn
-
1993
- 1993-01-12 ES ES93100339T patent/ES2161698T3/es not_active Expired - Lifetime
- 1993-01-12 EP EP93100339A patent/EP0554670B1/de not_active Expired - Lifetime
- 1993-01-12 AT AT93100339T patent/ATE205255T1/de active
- 1993-01-12 DE DE59310204T patent/DE59310204D1/de not_active Expired - Lifetime
- 1993-02-05 NO NO93930406A patent/NO930406L/no unknown
- 1993-02-05 CA CA002088889A patent/CA2088889C/en not_active Expired - Fee Related
- 1993-02-05 AU AU32836/93A patent/AU669870B2/en not_active Ceased
- 1993-02-08 JP JP04317293A patent/JP3821858B2/ja not_active Expired - Fee Related
-
1995
- 1995-06-06 US US08/467,393 patent/US5686583A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2088889C (en) | 2009-08-25 |
NO930406D0 (no) | 1993-02-05 |
NO930406L (no) | 1993-08-09 |
US5686583A (en) | 1997-11-11 |
AU669870B2 (en) | 1996-06-27 |
JP3821858B2 (ja) | 2006-09-13 |
JPH06133768A (ja) | 1994-05-17 |
EP0554670A2 (de) | 1993-08-11 |
AU3283693A (en) | 1993-08-12 |
DE4203545A1 (de) | 1993-08-12 |
EP0554670A3 (en) | 1994-07-13 |
EP0554670B1 (de) | 2001-09-05 |
DE59310204D1 (de) | 2001-10-11 |
CA2088889A1 (en) | 1993-08-08 |
ATE205255T1 (de) | 2001-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2081857T3 (es) | Nuevos inhibidores de alpha-glucosidasa. | |
ES2085075T3 (es) | Imidas y sus sales, asi como su uso como agentes tensioactivos. | |
NO982062L (no) | Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav | |
TR199501021A2 (tr) | Vücut agirligi modülatörüne tekabül eden nükleik asitler ve proteinler ve bunlarin diagnostik ve terapötik kullanimlari. | |
SV1996000033A (es) | Isotiazolonas | |
NO963239L (no) | Klorpyrimid-mellomprodukter | |
PT641343E (pt) | Derivados de 4-mercaptoacetilamino-¬2|benzazapinona (3) e a sua utilizacao como inibidores de encefalinase | |
BR9806764A (pt) | Moléculas mutantes ctla4 solúveis e usos das mesmas. | |
BR9408292A (pt) | Antigens de esperma correspondente a um epitojo auto- antigênico de uma proteina de ligação a zona de esperma | |
ES2035668T3 (es) | Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma. | |
HN1998000088A (es) | Tratamiento de resistencia a la insulina | |
HN1998000169A (es) | Uso de aminometilcromano sustituidos para el impedimento de la degeneracion neuronal y para el estimulo de la regeneracion neuronal. | |
ES2153113T3 (es) | Compuestos de benzotiofeno. | |
ES2193197T3 (es) | Craquizacion catalitica com mcm-49. | |
MX9302614A (es) | Receptor de glutamato metabotropico humano y compuestos de dna relacionados. | |
DE69010294D1 (de) | Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs. | |
ES2161698T3 (es) | Anticuerpos especificos contra plaquetas activadas, su produccion y su utilizacion en la diagnosis y terapia. | |
ES2192610T3 (es) | Aminouracilos substituidos. | |
PT734380E (pt) | 4-benzoilisoxazois e sua utilizacao como herbicidas | |
ES2138624T3 (es) | Combinaciones terapeuticas. | |
ES2117475T5 (es) | Utilizacion de acidos monocarboxilicos para el tratamiento de las materias queratinicas. | |
BR0113172A (pt) | Corpos enformados planos flexìveis, revestidos | |
ID23184A (id) | Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi | |
ES2056876T3 (es) | Compuestos piperidinilicos 1,4-disustituidos. | |
ATE317021T1 (de) | Antisense modulierung von lfa-3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 554670 Country of ref document: ES |